You pulled the short straw. A night shift, a red eye, a newborn, an exam you left too late. Now you need your brain to work anyway, and somewhere online you read that creatine, of all things, might help. Not caffeine. The gym supplement.

Here is the short version before we go deep. There is a genuinely interesting and growing body of research suggesting that creatine can blunt some of the cognitive damage of sleep deprivation, and the newest studies are the most striking ones. But the doses used in the headline experiments are far larger than anything you would find on a supplement label, the studies are small, and the same ingredient has repeatedly failed to improve cognition in people who are well rested. If you came here hoping for a simple yes or no on creatine and sleep deprivation, the honest answer is: yes, probably, under specific conditions, at doses nobody actually takes, with plenty still unproven. Let me walk you through why I land there.

Why Sleep Loss Is an Energy Problem

Your brain runs on adenosine triphosphate, usually shortened to ATP, the molecule cells use to move energy around. Creatine’s job in the body is to act as a rapid recharging system for ATP. Cells hold a reserve of phosphocreatine, which is creatine carrying a spare phosphate group, and when energy demand spikes, that reserve regenerates ATP faster than metabolism alone can manage.

Most people know this story from muscle, where creatine is one of the best supported sports supplements in existence. The brain runs the same system. It is a hungry organ, consuming roughly a fifth of your energy at rest, and imaging studies have long shown that staying awake through the night shifts brain energy metabolism in measurable ways. The researchers behind the most cited recent study in this area, a 2024 trial published in Scientific Reports, framed sleep deprivation and creatine as having roughly opposite effects on the brain’s high energy phosphate system. Sleep loss drains the battery. Creatine, in theory, tops it up.

That theory is older than the recent hype. What changed in the last two years is that researchers finally tested whether a single large dose could reach the brain fast enough to matter on the very night you need it. For years the assumption was that it could not, because the brain takes up creatine slowly and reluctantly. Which brings us to the study that put this topic in every supplement newsletter on the internet.

The Single Dose Study Everyone Is Citing

In February 2024, a group at the Jülich research center in Germany published the trial mentioned above. Healthy young adults stayed awake for 21 hours while researchers ran cognitive tests and magnetic resonance spectroscopy, a scanning technique that measures chemical concentrations inside the living brain. In one session participants swallowed a single dose of creatine monohydrate at 0.35 grams per kilogram of body weight. In the other session, on a different night, the same people got a placebo. The design was randomized, double blind, and crossover, which is a strong setup for a small study because every person serves as their own control.

The results were unusually clean for this field. Three hours after the dose, brain scans showed changes in phosphocreatine and related metabolites, and cognitive performance and processing speed held up better than under placebo. Reporting on the study, Medical News Today noted that the benefit peaked around four hours and lasted up to nine, with processing capacity and short term memory among the measures that improved. The authors concluded that a high single dose can partially reverse the metabolic changes and the fatigue related decline in thinking that sleep deprivation causes.

Now the caveat that most coverage skipped. That dose, 0.35 grams per kilogram, works out to roughly 25 grams of creatine for a 70 kilogram adult, taken all at once. A standard daily supplement dose is 3 to 5 grams. The study dose is about five to eight times that, swallowed in one sitting. The researchers chose it deliberately, on the hypothesis that flooding the bloodstream with creatine while the brain is under metabolic stress would temporarily push more of it across the blood brain barrier, the selective lining that controls what enters brain tissue. It seems to have worked. But a finding at 25 grams during enforced wakefulness tells you nothing direct about the 5 gram scoop in your kitchen cupboard, and I would treat anyone who blurs that line as selling you something.

The trial was also small, run in one lab, on young healthy adults, over a single night. None of that makes it wrong. It makes it a promising first result rather than a settled fact.

The Follow Up That Lowered the Dose

Good research groups try to break their own findings, and this group came back with a useful next step. In a follow up trial published in Nutrients, 29 healthy adults went through the same 21 hour sleep deprivation protocol, this time with a single dose of 0.2 grams per kilogram, which is about 14 grams for a 70 kilogram person. Testing ran at baseline in the evening and again at three points through the night, ending at 4:30 in the morning.

The lower dose still helped. The authors reported that creatine softened the sleep deprivation driven decline in logical and numerical tasks, in language related processing speed, and in the Psychomotor Vigilance Test, a standard reaction time task used in fatigue research. They describe the result as replicating and confirming the acute effect of a single dose during sleep loss.

This matters for two reasons. First, replication by the same group in a larger sample is exactly what you want to see after a striking small study, even if independent replication from a different lab would count for more. Second, 14 grams is still nearly three times a normal daily dose, but it is moving in a direction that makes real world use less absurd. What nobody has yet published, as far as my reading of this literature goes, is a sleep deprivation trial showing that an ordinary 3 to 5 gram dose taken on the night does anything at all. The dose response question below 0.2 grams per kilogram is simply open.

Worth knowing as well: the same cohort produced a further analysis of hemispheric brain energy use during sleep deprivation, which found that the right and left hemispheres burn through high energy phosphates unevenly during a night awake and that creatine appeared to balance the asymmetry. Interesting mechanism work, though I would not hang any purchasing decision on it.

The Older Studies That Started All This

The 2024 work did not come out of nowhere. Two decades earlier, Terry McMorris and colleagues ran the experiments that made creatine and sleep deprivation a research topic in the first place, and they deserve more attention than they get, partly because their results were messier than the summary sentences suggest.

In the 2006 study in Psychopharmacology, 19 healthy adults took either creatine or placebo at 5 grams four times a day for seven days, then stayed awake for 24 hours with intermittent mild exercise. The creatine group did better on random movement generation, a task that leans heavily on the prefrontal cortex, along with choice reaction time, balance, and mood. A companion study published in Physiology and Behavior in 2007 stretched the deprivation to 36 hours using the same 20 grams per day loading protocol and found a benefit on random movement generation at 36 hours.

Here is the inconvenient detail. When McMorris himself co authored a 2024 systematic review in Behavioural Brain Research, the group described these two sleep deprivation studies as somewhat equivocal. In the 2006 study, creatine helped on one executive task and one non executive task but showed no significant effect on four others. In the 2007 study, nothing reached significance at 24 hours. The review’s overall verdict on creatine and cognition was that the research, quote unquote, fails to support the theoretical basis for a general effect, while explicitly flagging stressed states like sleep deprivation as the one context where the signal looks real enough to keep studying. When the researcher who ran the original experiments tells you the picture is equivocal, believe him over the supplement ads citing his papers.

One more early study rounds out the acute picture. A 2011 trial with elite rugby players restricted ten athletes to three to five hours of sleep and tested a repetitive passing skill. Sleep restriction with placebo caused a significant drop in passing accuracy. Single doses of creatine at 50 or 100 milligrams per kilogram, roughly 3.5 to 7 grams for a 70 kilogram person, prevented that drop, as did caffeine at 1 or 5 milligrams per kilogram. Ten participants and a motor skill task is thin evidence, and note that this was partial sleep restriction rather than a full night awake. But it is the one acute study using doses close to what people actually take, and it pointed the same direction thirteen years before the Jülich work.

What Happens Without Sleep Deprivation

Now for the part that separates this site from the hype machine. If creatine were a general brain booster, you would expect it to help rested people too. Mostly, it does not, and the best designed study in the whole literature is a null result.

The 2023 Sandkühler trial in BMC Medicine is the largest randomized controlled trial of creatine for cognition to date: 123 healthy adults, half vegetarian and half omnivore, taking 5 grams daily for six weeks in a preregistered, double blind, placebo controlled crossover design. It was built to replicate a famous 2003 study by Caroline Rae’s group that had found large gains in working memory and abstract reasoning in vegetarians. The replication found no significant effect on either primary outcome, none on eight exploratory cognitive tests, and no special benefit for vegetarians. The working memory measure trended in creatine’s favor without reaching significance. As replications of celebrated findings go, this one was close to a wipeout, and it was roughly three times the size of the original.

The meta analyses, which pool many trials into one estimate, look superficially kinder but wobble under inspection. A 2023 meta analysis in Nutrition Reviews by Prokopidis and colleagues initially reported that creatine improved memory in healthy individuals. Then came a letter from Eckert and Pascher pointing out that the analysis had double counted, meaning it treated multiple test scores from the same participants as if they were independent data points, a statistical error that inflates certainty. When the authors reanalyzed correctly, the overall memory effect was no longer significant. What survived was a benefit in older adults aged roughly 66 to 76. That is a genuinely interesting surviving result, and it is a much narrower claim than the original headline.

A 2024 meta analysis by Xu and colleagues in Frontiers in Nutrition pooled 16 trials with 492 participants and reported modest effects on memory, attention time, and processing speed, with moderate certainty for memory and no effect on overall cognition or executive function. It has since picked up a corrigendum correcting the wording of its attention findings, and its pooling methods have drawn the same double counting criticism, including from regulators, which we are about to get to. The pattern across all of this is consistent enough to state plainly: in rested, healthy, young adults, daily creatine has never convincingly improved cognition, and the strongest trial found nothing. Whatever creatine does for a sleep deprived brain, it is not a smart drug for a rested one.

What Regulators Concluded When They Read Everything

In November 2024, the European Food Safety Authority published a formal opinion on creatine and cognitive function, after the creatine manufacturer Alzchem applied for permission to claim cognitive benefits on products sold in the EU. EFSA panels do the tedious work most of us skip: they read every submitted study, grade the methods, and decide whether a cause and effect relationship is established. Their answer was no.

The reasoning is worth reading because it maps exactly onto the dose problem this article keeps circling. The panel noted that acute effects on working memory appeared in studies using 20 grams per day for five to seven days but not at lower doses of roughly 2 to 14 grams, and not with continuous 5 gram daily use over six weeks. An effect on response inhibition at 20 grams per day was an isolated finding among ten studies in healthy people. The panel also judged the mechanistic evidence weak and found that the old McMorris sleep deprivation studies had methodological limitations, including uncorrected multiple comparisons, that prevented drawing conclusions from them. A UK committee reviewing a parallel application reached a similarly unimpressed position.

Two clarifications so this lands correctly for readers in the United States. First, EFSA’s ruling binds product claims in the EU, not here. In the US, the FDA does not preapprove the structure and function claims you see on supplement labels; companies are responsible for substantiating them, and the FTC can act when they cannot. So an American label touting brain benefits has not passed any review EFSA style, which is worth remembering when you shop. Second, an EFSA rejection is not a finding that creatine does nothing. It is a finding that the evidence, weighed strictly, does not yet establish the claim. Notably, the single dose sleep deprivation work was barely part of that picture, since a one time 25 gram experimental dose is not how anyone markets a food supplement. The regulators and the Jülich researchers are not actually contradicting each other. They are answering different questions.

The Delivery Problem Nobody Should Gloss Over

Underneath all of this sits an unglamorous physiological fact: the brain does not soak up supplemental creatine the way muscle does. The brain makes some of its own creatine, and transport from blood into brain tissue depends on a carrier protein called SLC6A8, which is present at the blood brain barrier in limited amounts.

The measurement studies bear this out. A 2022 review by Forbes and colleagues in Nutrients summarized a dozen brain imaging studies and found that supplementation changed brain creatine content anywhere from a drop of 0.7 percent to a rise of 14.6 percent, with most studies landing in a 3 to 10 percent increase after weeks of dosing. Compare that with the roughly 20 percent increases routinely measured in muscle. Two studies in that set found no brain increase at all. A 2025 commentary on creatine and cognitive aging put it bluntly: whether supplemented creatine crosses into the brain in amounts sufficient to change neuronal metabolism remains a key uncertainty, and claims of cognitive enhancement built on supplementation alone risk overstating the data.

This is exactly why the single dose sleep deprivation results are scientifically interesting rather than just another supplement study. The Jülich group’s working hypothesis is that metabolic stress changes the equation, that a brain burning through its energy reserves while awash in blood creatine pulls in more than a rested brain would. Their spectroscopy data, showing raised brain creatine signals within hours of a large dose during sleep deprivation, is the first decent human evidence for that idea. It is also, so far, evidence from one lab. If you have been reading supplement marketing that claims some special formulation solves the brain delivery problem, know that no finished product has published evidence of doing any such thing. The delivery question is a live research topic, not a solved one.

What the Studies Used Versus What People Actually Do

Let me lay the doses side by side, because this is where readers get misled most often.

The 2024 Scientific Reports trial used a single dose of 0.35 grams per kilogram, about 25 grams for a 70 kilogram adult, during 21 hours awake. The follow up used 0.2 grams per kilogram, about 14 grams, same protocol. The McMorris studies used 20 grams per day for seven days before the sleepless night. The rugby study used single doses of roughly 3.5 to 7 grams before testing after three to five hours of sleep. The null Sandkühler trial and most of the daily dosing literature used 5 grams per day.

What people actually do is take 3 to 5 grams daily, often for muscle reasons, and hope the brain benefits come along free. Nothing in the sleep deprivation literature directly tests that habit. It is plausible that weeks of daily dosing raises brain creatine a few percent and provides a small buffer on a bad night, and the older loading studies are loosely consistent with that. It is equally plausible that the acute effect requires the big circulating spike the German trials engineered. Nobody has run the study that settles it. Timing is another open question, since the trials dosed in the early evening, hours before the worst of the night, and nothing tells us whether taking creatine at 3 in the morning, once you are already struggling, works the same way. If your plan is to keep a tub in the break room for emergencies, the honest reading is that you would be running an experiment on yourself that the literature has not yet run.

I will also flag the practical reality of the experimental doses. Twenty five grams of creatine in one sitting is a lot, and digestive discomfort is a commonly reported issue at high single doses. The trials were supervised experiments on screened healthy volunteers, not a recommendation, and anyone with kidney disease or on medication has extra reason to involve a doctor before touching high doses of anything. For what it is worth, standard daily creatine doses have a long and reassuring safety record in healthy adults, which is one reason researchers feel comfortable pushing the experimental envelope. High single doses are simply a different, less studied situation, and this site is not going to pretend otherwise.

Creatine Next to Caffeine, Honestly

The comparison every sleep deprived reader actually wants. Caffeine remains the best evidenced acute countermeasure for sleepiness we have, full stop. It works within half an hour, at doses everyone already understands, with decades of military and shift work research behind it. Creatine is not about to replace it.

The interesting distinction is mechanistic. Caffeine does not give your brain energy; it blocks adenosine receptors so you stop feeling how tired you are. Creatine, if the recent work holds up, addresses the energy deficit itself, which is a different lever entirely. The rugby study tested them head to head in its small way and found both prevented the skill decline, with low dose caffeine performing as well as high dose. And caffeine’s costs are familiar: it can wreck your next night’s sleep, and tolerance blunts it. Creatine taken at night did not appear to disrupt the sleep architecture questions those trials looked at, though that was not their focus. A cocktail approach is exactly what night shift researchers are now curious about, and it is unstudied. If you take one thing from this section, take this: on current evidence, caffeine is the tool, and creatine is the experiment.

What Would Change the Picture

I said at the top that the honest answer on creatine and sleep deprivation is a qualified yes, and I want to end by naming the qualifications precisely, because they double as a list of what to watch for.

An independent replication of the single dose effect, from a lab with no connection to the Jülich group, would move this from promising to probably real. A dose response study reaching down to 5 grams would tell us whether normal supplementation does anything acutely, and the researchers’ own trajectory from 25 grams down to 14 suggests they are headed there. A trial in actual shift workers, older adults, or chronically short sleepers rather than young volunteers kept awake once would tell us whether the effect survives contact with the real world. And a study measuring next day performance after recovery sleep would answer whether creatine helps you through the night or merely shifts the deficit.

Until then, here is where a close reading of the research leaves things. Daily creatine has repeatedly failed to sharpen rested young brains, and the strongest trial found nothing. The one population level exception with some surviving statistical support is older adults’ memory. Under sleep deprivation, the picture flips: two modern, well designed crossover trials, several older studies, and a plausible energy mechanism all point toward a genuine protective effect, at doses well above normal use, established in small samples from a narrow research base. That is more evidence than most nootropic claims will ever have, and less than a confident recommendation requires. If you are sleep deprived tonight, the study backed advice is boring: caffeine carefully, a nap if you can steal one, and real sleep as soon as possible. Creatine’s night shift is coming, but the science is still clocking in.